IEX •
Consumer Defensive •
Packaged Foods •
Quote as of 05/14/2026 15:59
Company Profile
IndustryPackaged Foods
SectorConsumer Defensive
ExchangeIEX
Market Capitalization78.44 mln
Float8.56 mln
Earnings Date05/14/2026
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-3.09
Reliable
1-Year Forecast
30.67
Transformational upside
Relative Strength
92
/ 100
Top performer
Debt / Equity
-1.23
Negative equity
Dividend Yield
0.00%
No dividend
Business Description
Clene Inc. is a clinical-stage pharmaceutical company based in Salt Lake City, Utah, focused on developing treatments using a proprietary nanoparticle technology. Its primary drug candidate, CNM-Au8, is a gold nanoparticle suspension that has been tested in multiple Phase 2 trials targeting serious neurological conditions such as ALS, Multiple Sclerosis, and Parkinson's Disease. The company is also developing silver and zinc-based compounds aimed at treating infections and supporting wound healing. In addition to its drug pipeline, Clene sells a small range of dietary supplements containing low-concentration gold, silver, and zinc nanoparticles.
